Disclosures for "Efficacy and Safety Results of INFRONT-3: A Phase 3 Randomized, Double-Blind, Placebo Controlled Study Evaluating Latozinemab (AL001) in FTD-GRN "
-
Dr. MAYORGA has received personal compensation for serving as an employee of Alector, Inc.. Dr. MAYORGA has or had stock in Alector.
-
Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
-
Dr. Le Ber has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail Therapeutics. Dr. Le Ber has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector.
-
Dr. Borroni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Borroni has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
-
Dr. Mummery has nothing to disclose.
-
Dr. Rohrer has nothing to disclose.
-
Dr. Zamboni has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eli Lilly . The institution of Dr. Zamboni has received research support from European Research Council.
-
Prof. Onur has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Prof. Onur has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Prof. Onur has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GE.
-
James Rowe, BA BM BCh PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. James Rowe, BA BM BCh PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SV Health. James Rowe, BA BM BCh PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astex. James Rowe, BA BM BCh PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Asceneuron. James Rowe, BA BM BCh PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GE Healthcare. The institution of James Rowe, BA BM BCh PhD has received research support from Janssen. The institution of James Rowe, BA BM BCh PhD has received research support from Lilly. The institution of James Rowe, BA BM BCh PhD has received research support from AZ Medimmune. James Rowe, BA BM BCh PhD has received publishing royalties from a publication relating to health care.
-
An immediate family member of Dr. Boxer has received personal compensation for serving as an employee of Kaiser Permanente. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oscotec. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Switch. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvinas. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alector. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Transposon. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Boxer has stock in Alector. Dr. Boxer has stock in Arvinas. Dr. Boxer has stock in Neurovanda. The institution of Dr. Boxer has received research support from Biogen. The institution of Dr. Boxer has received research support from Eisai. The institution of Dr. Boxer has received research support from Regeneron. The institution of Dr. Boxer has received research support from NIH. The institution of Dr. Boxer has received research support from Bluefield Project-5. Dr. Boxer has received research support from Rainwater Charitable Foundation. Dr. Boxer has received research support from GHR Foundation. Dr. Boxer has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Schwabe has received personal compensation for serving as an employee of Nine Square Therapeutics. Dr. Schwabe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for MarinerBio Consulting LLC. Dr. Schwabe has or had stock in Alector.
-
Dr. Kahn has received personal compensation for serving as an employee of Alector. Dr. Kahn has or had stock in Alector .
-
Dr. Huang has received personal compensation for serving as an employee of Alector, Inc. Dr. Huang has stock in Alector.
-
Dr. Gupta has nothing to disclose.
-
Ms. Zhong has received personal compensation for serving as an employee of Alector.
-
Dr. Li has nothing to disclose.
-
The institution of Dr. Guizzetti has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Everest Clinical Research.
-
Dr. Carter has received personal compensation for serving as an employee of Alector. Dr. Carter has stock in Alector. Dr. Carter has stock in Jazz Pharmaceuticals.
-
Mr. Nguyen has received personal compensation for serving as an employee of Alector.
-
Dr. Simmons has received personal compensation for serving as an employee of Alector. Dr. Simmons has or had stock in AstraZeneca.
-
Dr. Chow has received personal compensation for serving as an employee of Alector, Inc.. Dr. Chow has stock in Alector, Inc.. Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant on grant U19AG079774 with NIA.
-
Dr. Budda has received personal compensation for serving as an employee of Alector. Dr. Budda has received personal compensation for serving as an employee of Acceleron Pharma. Dr. Budda has stock in Alector. Dr. Budda has stock in Acceleron Pharma.
-
Dr. Park has received personal compensation for serving as an employee of Eli Lilly. Dr. Park has received personal compensation for serving as an employee of Alector. Dr. Park has received personal compensation for serving as an employee of Supernus . Dr. Park has received personal compensation for serving as an employee of Parexel .
-
Dr. Jackson has received personal compensation for serving as an employee of Neuron23. Dr. Jackson has received personal compensation for serving as an employee of Aditum Bio . Dr. Jackson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aerska Biotech. Dr. Jackson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autonomy Bio. Dr. Jackson has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Paul has received personal compensation for serving as an employee of Alector. Dr. Paul has received stock or an ownership interest from Alector.
-
Dr. Romano has received personal compensation for serving as an employee of Alector. Dr. Romano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ALector. Dr. Romano has or had stock in Alector.
-
Dr. Kenkare-Mitra has received personal compensation for serving as an employee of Alector, Inc..
-
Dr. Rosenthal has received personal compensation for serving as an employee of Alector. Dr. Rosenthal has or had stock in Alector.
-
Dr. Salvadore has received personal compensation for serving as an employee of Alector, Inc. Dr. Salvadore has stock in Alector, Inc..